Medios AG (ETR:ILM1)
10.90
-0.02 (-0.18%)
Aug 26, 2026, 5:35 PM CET
Medios AG Revenue
Medios AG had revenue of 551.00M EUR in the quarter ending June 30, 2026, with 8.52% growth. This brings the company's revenue in the last twelve months to 2.17B, up 9.81% year-over-year. In the year 2025, Medios AG had annual revenue of 2.08B with 10.49% growth.
Revenue (ttm)
2.17B
Revenue Growth
+9.81%
P/S Ratio
0.12
Revenue / Employee
2.19M
Employees
989
Market Cap
267.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.08B | 197.73M | 10.49% |
| Dec 31, 2024 | 1.89B | 98.27M | 5.50% |
| Dec 31, 2023 | 1.79B | 173.07M | 10.72% |
| Dec 31, 2022 | 1.61B | 253.99M | 18.67% |
| Dec 31, 2021 | 1.36B | 732.77M | 116.80% |
| Dec 31, 2020 | 627.36M | 67.18M | 11.99% |
| Dec 31, 2019 | 560.17M | 231.09M | 70.22% |
| Dec 31, 2018 | 329.09M | 74.14M | 29.08% |
| Dec 31, 2017 | 254.95M | 121.74M | 91.38% |
| Dec 31, 2016 | 133.21M | 74.99M | 128.81% |
| Dec 31, 2015 | 58.22M | 53.74M | 1,198.50% |
| Dec 31, 2014 | 4.48M | 2.71M | 153.23% |
| Dec 31, 2013 | 1.77M | -42.57M | -96.01% |
| Jan 31, 2013 | 44.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| MEDICLIN Aktiengesellschaft | 819.84M |
| Evotec SE | 717.28M |
| M1 Kliniken AG | 364.30M |
| Stratec SE | 244.81M |
Medios AG News
- 13 days ago - EQS-PVR: Medios AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 13 days ago - EQS-DD: Medios AG: Stefan Bauerreis, buy - Wallstreet:Online
- 14 days ago - Medios AG Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - Medios AG Slides: Q2 2026 - Filings
- 14 days ago - Medios AG Quarterly report: Q2 2026 - Filings
- 14 days ago - Medios AG Earnings release: Q2 2026 - Filings
- 15 days ago - EQS-Adhoc: Medios AG – Acquisition of a Majority Stake in Caesar & Loretz GmbH (Caelo) and Entry into the German Market for Active Pharmaceutical Ingredients and Excipients - Wallstreet:Online
- 4 weeks ago - Medios AG Transcript: Investor update - Transcripts